WallStreetZenWallStreetZen

NASDAQ: ATON
Alphaton Capital Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ATON

Based on 1 analyst offering 12 month price targets for Alphaton Capital Corp

Min Forecast
$2.00+525%
Avg Forecast
$2.00+525%
Max Forecast
$2.00+525%

Should I buy or sell ATON stock?

Based on 1 analyst offering ratings for Alphaton Capital Corp.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ATON stock forecasts and price targets.

ATON stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-24

1 of 1

Forecast return on equity

Is ATON forecast to generate an efficient return?

Company
-0.61%
Industry
66.61%
Market
156.87%
ATON's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ATON forecast to generate an efficient return on assets?

Company
-0.19%
Industry
31.18%
ATON is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ATON earnings per share forecast

What is ATON's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.01
Avg 2 year Forecast
$0.13
Avg 3 year Forecast
$0.14

ATON revenue forecast

What is ATON's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$39.2M
Avg 2 year Forecast
$41.1M
Avg 3 year Forecast
$43.2M

ATON vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATON$0.32$2.00+525.00%Buy
PPCB$0.11N/AN/A
CNSP$2.46N/AN/A
INM$0.72N/AN/A
NCEL$3.38N/AN/A
View Top Biotech Stocks

Alphaton Capital Stock Forecast FAQ

Is Alphaton Capital Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ATON) stock is to Buy ATON stock.

Out of 1 analyst, 0 (0%) are recommending ATON as a Strong Buy, 1 (100%) are recommending ATON as a Buy, 0 (0%) are recommending ATON as a Hold, 0 (0%) are recommending ATON as a Sell, and 0 (0%) are recommending ATON as a Strong Sell.

If you're new to stock investing, here's how to buy Alphaton Capital stock.

What is ATON's earnings growth forecast for 2029-2031?

(NASDAQ: ATON) Alphaton Capital's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.65%.

Alphaton Capital's earnings in 2026 is -$14,894,000.On average, 3 Wall Street analysts forecast ATON's earnings for 2029 to be -$58,538, with the lowest ATON earnings forecast at -$56,242, and the highest ATON earnings forecast at -$60,260. On average, 3 Wall Street analysts forecast ATON's earnings for 2030 to be $760,991, with the lowest ATON earnings forecast at $731,149, and the highest ATON earnings forecast at $783,374.

In 2031, ATON is forecast to generate $819,529 in earnings, with the lowest earnings forecast at $787,391 and the highest earnings forecast at $843,633.

What is ATON's revenue growth forecast for 2029-2031?

(NASDAQ: ATON) Alphaton Capital's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.33%.

Alphaton Capital's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast ATON's revenue for 2029 to be $225,135,231, with the lowest ATON revenue forecast at $216,308,649, and the highest ATON revenue forecast at $231,758,037. On average, 3 Wall Street analysts forecast ATON's revenue for 2030 to be $235,614,645, with the lowest ATON revenue forecast at $226,374,855, and the highest ATON revenue forecast at $242,547,357.

In 2031, ATON is forecast to generate $248,142,882 in revenue, with the lowest revenue forecast at $238,409,538 and the highest revenue forecast at $255,442,890.

What is ATON's forecast return on assets (ROA) for 2029-2029?

(NASDAQ: ATON) forecast ROA is -0.19%, which is lower than the forecast US Biotechnology industry average of 31.18%.

What is ATON's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ATON price target, the average ATON price target is $2.00, with the highest ATON stock price forecast at $2.00 and the lowest ATON stock price forecast at $2.00.

The Wall Street analyst predicted that Alphaton Capital's share price could reach $2.00 by Feb 24, 2027. The average Alphaton Capital stock price prediction forecasts a potential upside of 525% from the current ATON share price of $0.32.

What is ATON's Earnings Per Share (EPS) forecast for 2029-2031?

(NASDAQ: ATON) Alphaton Capital's current Earnings Per Share (EPS) is -$8.01. On average, analysts forecast that ATON's EPS will be -$0.01 for 2029, with the lowest EPS forecast at -$0.01, and the highest EPS forecast at -$0.01. On average, analysts forecast that ATON's EPS will be $0.13 for 2030, with the lowest EPS forecast at $0.13, and the highest EPS forecast at $0.14. In 2031, ATON's EPS is forecast to hit $0.14 (min: $0.14, max: $0.15).

What is ATON's forecast return on equity (ROE) for 2029-2029?

(NASDAQ: ATON) forecast ROE is -0.61%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.